Management of type 2 diabetes through dietary changes has gained significant traction, with recent studies suggesting that fasting diets could be a key component in achieving better health outcomes, including potential remission of the disease.
Fasting diets, characterized by restricted calorie intake during specific periods, have demonstrated efficacy in alleviating symptoms of type 2 diabetes.
A prior randomized controlled trial indicated that a fasting-mimicking diet, which limits calorie intake for five consecutive days each month, could substantially lower blood sugar levels and diminish dependence on diabetes medications.
This emerging evidence is bolstered by findings from a recent study, which offers real-world proof of the benefits of a 5-day fasting-mimicking diet, extending beyond the confines of previous clinical trials.
According to reports published in 2021, approximately 11% of the American population had diabetes, with type 2 diabetes making up 90% to 95% of these cases.
The fasting diet approach, which incorporates alternating fasting and eating periods, has been touted for alleviating symptoms of diabetes and may be more sustainable than long-term calorie restriction.
The latest research illustrates that individuals with type 2 diabetes who engage in a fasting diet involving a 5-day limited energy intake each month can experience notable improvements in blood glucose levels, weight loss, and a reduced reliance on diabetes medications.
The fasting-mimicking diet, developed by the nutrient technology company L-Nutra, has been patented and is being promoted as a comprehensive approach to diabetes management.
Dr. William Hsu, an endocrinologist and Chief Medical Officer at L-Nutra, emphasized the study’s implications for real-world applications. He stated, “This study demonstrates how the fasting-mimicking diet (FMD), when combined with physician oversight and registered dietitian (RD) coaching, can be safely and effectively implemented in real-world clinical settings to manage type 2 diabetes.”
These promising findings were presented at the American Diabetes Association’s 85th Scientific Sessions on June 20, 2025, although they have yet to undergo peer review.
Traditionally, type 2 diabetes treatment combines lifestyle adjustments with medications. These lifestyle changes, particularly dietary modifications and increased physical activity, are vital for lowering blood glucose levels and facilitating weight loss.
While medications like metformin and GLP-1 agonists play a role in managing diabetes symptoms, true disease remission strongly correlates with lifestyle adjustments.
Research has affirmed that calorie restriction can effectively manage blood sugar levels and support weight loss among individuals living with type 2 diabetes.
However, the challenge of adhering to such dietary changes long-term remains a barrier.
Over time, the body adapts to sustained calorie deficits, often resulting in a slowed metabolism that complicates ongoing weight management.
As a solution, various fasting diets, which alternate between fasting and unrestricted eating periods, have been proposed as easier alternatives that still yield significant health benefits.
Fasting initiates a cellular stress response that is thought to promote healthy aging by lowering inflammation and oxidative damage while enhancing metabolism.
Methods of fasting may fall into intermittent fasting, where calorie intake is restricted during certain hours of the day, or periodic fasting, which involves designated fasting days.
The fasting-mimicking diet represents a type of periodic fasting that limits calorie intake for 4 to 7 consecutive days once a month.
Researchers designed this dietary approach to imitate the health benefits of prolonged water-only fasting while allowing for some caloric intake, thereby enhancing adherence.
The current study rests on this foundation, revealing that a 5-day fasting-mimicking diet correlates with decreased blood sugar and insulin levels while elevating ketone body levels, which may promote fat burning and ketosis.
Another randomized controlled trial has previously shown that coupling a fasting-mimicking diet with medication prompts better blood glucose control than medications alone.
These findings, gathered in a rigorous clinical setting, underscore the necessity of assessing this intervention’s efficacy in real-world scenarios.
The present study collected data from participants enrolled in a diabetes management program, in which they followed a monthly 5-day fasting-mimicking diet under the supervision of healthcare professionals.
Enrollment was conducted on a rolling basis, and data were evaluated from individuals who completed either 3 or 6 months of the program.
Results indicated that after three and six months, the fasting-mimicking diet was effective in facilitating weight loss and reducing glycated hemoglobin levels—a key marker of blood glucose.
Additionally, the program enabled a greater percentage of participants to achieve desirable blood glucose control compared to levels recorded at enrollment.
Participants also reported reduced medication dependencies for blood glucose management, maintaining high levels of engagement throughout the program.
Hsu remarked on the feasibility of integrating the fasting-mimicking diet into daily life, highlighting that the 5-day monthly regimen is manageable alongside work and family commitments.
He noted that support from registered dietitians helps participants adopt practical strategies for adherence and personalization of the diet.
While the fasting-mimicking diet is generally safe for most individuals with type 2 diabetes, consulting a physician prior to commencing such a dietary program is recommended.
However, caution was expressed by Michelle Routhenstein, a preventive cardiology dietitian, who was not involved in the study.
She pointed out that although the FMD program’s positive effects on weight and blood sugar are encouraging, a notable number of participants experienced common signs of energy deficit, such as fatigue, headache, dizziness, and nausea during the 5-day fasting phase.
As research continues to evolve on dietary approaches to managing type 2 diabetes, findings from this latest study reinforce the potential of innovative diets, like the fasting-mimicking diet, in enhancing patient outcomes.
image source from：medicalnewstoday
